GLP-1 agonists in Canada were previously only available as injections, ranging from twice-daily to once-weekly
Associations of Glycemic Index and Glycemic Load with cardiovascular disease: updated evidence from meta-analysis and cohort studies
These data come from Cosmos, a dataset created in collaboration with a community of Epic health systems representing more than 300 million patient records from 1,900 hospitals and more than 42,000 clinics from all 50 U.S
Estos son algunos de los hallazgos de las investigaciones recientes que muestran qu puede suceder cuando dejas de tomar un GLP-1, adems de consejos de expertos sobre cmo mantener los beneficios para la salud que muchas personas obtienen de los medicamentos
SAHPRA has confirmed that no oral GLP-1 solutions have been approved for use in the country
Hydration needs should be individualized based on activity level, climate, and comorbidities